IBB

iShares NASDAQ Biotechnology ETF
A

80
*Unless otherwise stated, data provided by FactSet.

IBB Fund Description

IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

IBB Factset Analytics Insight

The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.

IBB MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of December 17, 2018 the iShares NASDAQ Biotechnology ETF MSCI ESG Fund Quality Score is 4.78 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. IBB ranks in the 51st percentile within its peer group and in the 25th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

IBB CHARTS AND PERFORMANCE

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 12/17/18] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IBB -4.57% -13.71% -5.95% -5.69% -3.04% 7.30% 16.05%
IBB (NAV) 0.03% -13.43% -4.34% -2.75% -1.36% 7.43% 16.70%
NASDAQ Biotechnology Index -- -- -- -- -- -- 16.70%
Thomson Reuters US Biotechnology & Medical Research -4.15% -14.59% -4.97% -4.53% -0.21% 10.17% --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IBB Top 10 Countries

IBB Top 10 Sectors

IBB Top 10 Holdings [View All]

IBB Summary Data

BlackRock
iShares
02/05/01
Open-Ended Fund
0.47%
$8.01B
$216.80M
0.08%

IBB Portfolio Data

$38.23B
-107.57
5.15
0.31%
12/17/18
188

IBB Index Data

Market Cap
NASDAQ - Listed
Thomson Reuters US Biotechnology & Medical Research

IBB Portfolio Management

0.47%
-0.40%
-0.30%
-0.47%

IBB Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IBB Fund Structure

Open-Ended Fund
No
Yes
72% / 29%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

IBB Factset Analytics Block Liquidity

As of 12/18/18
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBB. IBB is rated a 5 out of 5.

IBB Tradability

2,046,894
$216.80M
1,756,898
$188.23M
0.08%
$0.08
-0.01%
0.54% / -0.29%
None
100.00%
50,000
35.14
0.01%
0.09%
182,139
$101.95
5

IBB Sector/Industry Breakdown


IBB
Segment Benchmark
62.56%
85.54%
24.12%
0.51%
6.68%
--
3.79%
4.23%
0.25%
0.54%
0.19%
--
0.13%
0.17%
0.07%
0.32%

IBB Countries


IBB
Segment Benchmark
95.06%
100.00%
2.28%
--
0.93%
--
0.66%
--
0.40%
--
0.35%
--
0.13%
--
0.13%
--
0.06%
--

IBB Regions


IBB
Segment Benchmark
95.12%
100.00%
4.21%
--
0.66%
--

IBB Economic Development


IBB
Segment Benchmark
100.00%
100.00%

IBB Performance Statistics

0.96
0.92
0.90
0.92
0.31%
Thomson Reuters US Biotechnology & Medical Research

IBB MSCI ESG Ratings

4.78 / 10
50.75
24.73
--
34.99%
20.12

IBB BENCHMARK COMPARISON HOLDINGS

188
148
107
48.98%

IBB BENCHMARK COMPARISON SUMMARY


IBB
Segment Benchmark
188
148
$38.23B
$31.30B
-107.57
-50.96
5.15
5.29
0.52%
0.72%
Medium
High

IBB BENCHMARK COMPARISON MARKET CAP SIZE


IBB
Segment Benchmark
58.87%
47.81%
23.52%
29.46%
14.87%
19.75%
2.75%
2.97%

Options Strategies for Outcome Investing

Options allow you to customize investment outcomes. Using the strategy builders provided by Cboe Vest Technologies, you can construct some of the most common option strategies. Check out our user guide for more information on how to use the tool.

A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.